Resolvin D1 Attenuates Myocardial Infarction in a Rodent Model with the Participation of the HMGB1 Pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Resolvin D1 Attenuates Myocardial Infarction in a Rodent Model with the Participation of the HMGB1 Pathway
Authors
Keywords
Resolvin D1, Myocardial infarction, High mobility group box 1, Inflammation, Oxidative stress
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-06
DOI
10.1007/s10557-019-06884-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comprehensive targeted and non-targeted lipidomics analyses in failing and non-failing heart
- (2018) Ganesh V. Halade et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Paradigm shift – Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery
- (2018) Ganesh V. Halade et al. BIOTECHNOLOGY ADVANCES
- Immune responsive resolvin D1 programs myocardial infarction–induced cardiorenal syndrome in heart failure
- (2018) Ganesh V. Halade et al. FASEB JOURNAL
- Immune responsive resolvin D1 programs peritoneal macrophages and cardiac fibroblast phenotypes in diversified metabolic microenvironment
- (2018) Vasundhara Kain et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Down-regulation of nuclear HMGB1 reduces ischemia-induced HMGB1 translocation and release and protects against liver ischemia-reperfusion injury
- (2017) Guangyuan Zhao et al. Scientific Reports
- IL-23 Promotes Myocardial I/R Injury by Increasing the Inflammatory Responses and Oxidative Stress Reactions
- (2016) Xiaorong Hu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarction
- (2016) Monika Garg et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Reduced acute myocardial ischemia–reperfusion injury in IL-6-deficient mice employing a closed-chest model
- (2016) Willeke M. C. Jong et al. INFLAMMATION RESEARCH
- Combined morphine and limb remote ischemic perconditioning provides an enhanced protection against myocardial ischemia/reperfusion injury by antiapoptosis
- (2016) Shi-Yu Wang et al. JOURNAL OF SURGICAL RESEARCH
- Cardiac Oxidative Stress and Inflammatory Cytokines Response after Myocardial Infarction
- (2015) Margherita Neri et al. Current Vascular Pharmacology
- Resolvin D1 Reduces Infarct Size Through a Phosphoinositide 3-Kinase/Protein Kinase B Mechanism
- (2015) Kim Gilbert et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
- (2015) Vasundhara Kain et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Resolvin D1, a Metabolite of Omega-3 Polyunsaturated Fatty Acid, Decreases Post-Myocardial Infarct Depression
- (2014) Kim Gilbert et al. Marine Drugs
- Circulation : Clinical Summaries
- (2012) CIRCULATION
- Omega-3 fatty acids and their lipid mediators: Towards an understanding of resolvin and protectin formation
- (2012) Karsten H. Weylandt et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Omega-3 Fatty Acid-Derived Mediators 17(R)-Hydroxy Docosahexaenoic Acid, Aspirin-Triggered Resolvin D1 and Resolvin D2 Prevent Experimental Colitis in Mice
- (2011) A. F. Bento et al. JOURNAL OF IMMUNOLOGY
- Effects of n-3 Polyunsaturated Fatty Acids on Left Ventricular Function and Functional Capacity in Patients With Dilated Cardiomyopathy
- (2011) Savina Nodari et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Omega-3 Fatty Acids and Cardiovascular Disease
- (2011) Dariush Mozaffarian et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ischemia and reperfusion—from mechanism to translation
- (2011) Holger K Eltzschig et al. NATURE MEDICINE
- Postconditioning in Reperfusion Injury: A Status Report
- (2010) Zhi-Qing Zhao CARDIOVASCULAR DRUGS AND THERAPY
- Novel Lipid Mediators Promote Resolution of Acute Inflammation
- (2010) Matthew Spite et al. CIRCULATION RESEARCH
- Neutralization of the extracellular HMGB1 released by ischaemic-damaged renal cells protects against renal ischaemia-reperfusion injury
- (2010) J. Li et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mechanisms of Toll-Like Receptor 4 (TLR4)-Mediated Inflammation After Cold Ischemia/Reperfusion in the Heart
- (2009) David J. Kaczorowski et al. TRANSPLANTATION
- Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients
- (2008) Xiao Xiang Yan et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started